Nafa K, Bessler M, Deeg H J, Luzzatto L
Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Blood. 1998 Nov 1;92(9):3422-7.
We report a detailed longitudinal study of the first patient to be treated (in 1973) for paroxysmal nocturnal hemoglobinuria (PNH) with syngeneic bone marrow transplantation (BMT). The patient subsequently relapsed with PNH in 1983, and still has PNH to date. Analysis of the PIG-A gene in a recent blood sample showed in exon 6 an insertion-duplication causing a frameshift. Polymerase chain reaction (PCR) amplification of the PIG-A exon 6 from bone marrow (BM) slides obtained before BMT showed that the duplication was not present; instead, we found several single base pair substitutions in exons 2 and 6. Thus, relapse of PNH in this patient was not due to persistence of the original clones; rather, it was associated with the emergence of a new clone. These findings support the notion that the BM environment may create selective conditions favoring the expansion of PNH clones.
我们报告了首例阵发性夜间血红蛋白尿(PNH)患者(于1973年接受治疗)接受同基因骨髓移植(BMT)的详细纵向研究。该患者随后于1983年复发PNH,至今仍患有PNH。对近期一份血样中的PIG-A基因分析显示,外显子6存在导致移码的插入-重复。对BMT前获取的骨髓(BM)玻片进行PIG-A外显子6的聚合酶链反应(PCR)扩增显示不存在该重复;相反,我们在外显子2和外显子6中发现了几个单碱基对替换。因此,该患者PNH的复发并非由于原始克隆的持续存在;而是与一个新克隆的出现有关。这些发现支持了骨髓环境可能创造有利于PNH克隆扩增的选择性条件这一观点。